Tsegaselassie Workalemahu

Professor

University of Utah
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Mendelian randomization (MR) has become an important technique for establishing causal relationships between risk factors and health outcomes. By using genetic variants as instrumental variables, it can mitigate bias due to confounding and reverse causation in observational studies. Current MR analyses have predominantly used common genetic variants as instruments, which represent only part of the genetic architecture of complex traits. Rare variants, which can have larger effect sizes and provide unique biological insights, have been understudied due to statistical and methodological challenges. We introduce MR-common and annotation-informed rare variants (MR-CARV), a novel framework integrating common and rare genetic variants in two-sample MR. This method leverages comprehensive genetic data made available by high-throughput sequencing technologies and large-scale consortia. Rare variants are aggregated into functional categories, such as gene-coding, gene-noncoding, and nongene regions, by leveraging variant annotations and biological impact as weights. The effects of rare variant sets are then estimated with STAARpipeline and combined with the estimated effects of common variants by the existing MR methods. Simulation studies demonstrate that MR-CARV maintains robust type I error and achieves higher statistical power, with up to a 66.3% relative increase compared with existing methods only based on common variants. Consistent with these findings, application to real data on high-density lipoprotein cholesterol (HDL-C) and preeclampsia showed that MR-CARV [inverse variance weighted (IVW)] yielded a more precise and statistically significant effect estimate (–0.020, SE = 0.0102, $P$ =.0470) than IVW using only common variants (–0.023, SE = 0.0123, $P$ =.0659).

Year:

2026

Year:

2026

Objective Maternal genotypes may be useful to customise foetal growth assessment, but generalisability across diverse racial and ancestral groups remains uncertain. We assessed the generalisability of a genetic risk score for birth weight (GRS BW ), derived from participants of predominantly European ancestry, within a diverse U.S. cohort. Design Secondary analysis of a prospective observational cohort of nulliparous patients. Setting Eight U.S. recruitment centers. Population or Sample Participants in the parent study with available maternal DNA. Methods We used log‐linear modelling to test the association of maternal GRS BW with infant birth weight. We then assessed the robustness of the association by self‐identified race and genetically predicted continental ancestry (GPA) groups. Main Outcome Measures Birth weight. Results Among 8147 eligible participants, GRS BW was positively associated with birth weight ( p 0.09 for all). Among GPA groups, the association was significant among European (mean ratio 1.04, CI 1.02–1.07, p = 0.001) and American (mean ratio 1.08, CI 1.01–1.14, p = 0.02) ancestry groups but not African, East or South Asian, or unknown ancestry ( p > 0.05 for all). Conclusions This GRS BW is not generalisable across self‐described racial identities or GPA groups, highlighting the need for globally representative genetic discovery cohorts as well as further investigation into the complex role of race, ethnicity, and epigenetic influences on foetal growth.

Year:

2026

Year:

2026

Year:

2026

Objective The purpose of this study was to explore individuals' beliefs, values, and experiences surrounding stillbirth evaluation decisions. Design Qualitative research. Setting University of Utah Health. Population Parents who experienced a stillbirth in the past 5 years ( n = 19) were interviewed about their experiences and decision to consent to or decline stillbirth evaluations, such as autopsy, placental histopathology, or genetic testing. Methods Qualitative content analysis. Main Outcome Measures Barriers and facilitators to parentsstillbirth postmortem decision‐making. Results Participants communicated several facilitators and barriers that contributed to their stillbirth evaluation decision. Reasons for consenting to evaluations were belief in science, background in medicine, altruism, to inform future pregnancies, thinking about preventing another stillbirth, and how patients viewed the care of their stillborn by the medical team. Reasons for declining evaluations were receiving a diagnosis prior to being offered a postmortem evaluation, intent to avoid causing further harm to the baby, interest to spend more time with their baby, and cost of the evaluation. Conclusion Stillbirth is one of the most difficult experiences of a parent. Diagnostic and emotional barriers create further challenges to decision‐making for stillbirth postmortem evaluations. Parents often rely on inadequate information and personal values and beliefs during this time‐sensitive decision process. Decision support for stillbirth evaluations and training for medical providers could benefit parents, may increase stillbirth evaluation uptake, and potentially prevent decisional regret. Funding Research reported in this publication was supported by the Utah Centre for Excellence in ELSI Research (UCEER).

Year:

2025

Year:

2025

Background: Spontaneous preterm birth (SPTB) is the leading cause of neonatal morbidity and mortality. It is a final common pathway for multiple etiologies, some of which are well known while others likely remain to be identified. There is a genetic component to SPTB, but genetic mechanisms remain poorly defined. Well-characterized family-based studies may aid in identifying genetic contributors to SPTB. Objective : To identify inherited risk variants for SPTB using large pedigrees. Study Design : Using the Utah Population Database (UPDB), which links a 4.5 million-person genealogy to state birth certificate and fetal death records, we identified large pedigrees containing multiple women with early SPTB (<34 weeks’ gestation). We reviewed birth certificate data to exclude those with maternal and fetal diagnoses associated with iatrogenic preterm birth, resulting in 74 large multiplex pedigrees for early SPTB. Women with any SPTB (<37 weeks) within these early SPTB pedigrees were invited to participate. Enrolled women underwent comprehensive clinical phenotyping with review of primary medical records. Seven pedigrees, each containing at least 3 sampled women with SPTB, were the focus of this genetic study. High-density single-nucleotide polymorphism genotyping was conducted in maternal peripheral blood samples from women in the seven pedigrees. Shared genomic segment (SGS) analysis was performed to identify genome-wide significant chromosomal regions shared in excess by women with SPTB. Results : We identified two genome-wide significant regions. In single-pedigree SGS analyses, a 1.75 Mb genome-wide significant region at 8q24.23 was shared by 5 out of 6 women with SPTB in a single large pedigree (false positive rate per genome, µ=0.028). In duo-pedigree analysis, this region showed overlapping evidence with a second pedigree. The shared 1.05 Mb 8q24.23 locus had a more extreme false-positive rate (µ=0.0019). and contains FAM135B and KHDRBS3 genes, which have previously been implicated in oncogenesis and ovarian cancer. Duo-pedigree SGS analysis also identified a second genome-wide significant 67 kb locus at 12q21.1-q21.2 that was shared by all SPTB cases in two independent pedigrees (µ=0.01). The intersecting region at 12q21.1-q21.2 contains genes ( CAPS2 ; KCNC2 ) implicated in vascular-related complications of pregnancy and preterm labor. Conclusion : We identified two risk loci for SPTB using shared genomic segments analysis in large multiplex pedigrees. Identification of genes associated with SPTB may provide novel therapeutic targets for prevention and treatment to prolong pregnancy and improve outcomes.

Year:

2024

Collaborators (3)

Claire Roberts

Flinders University

AUSTRALIA
View details

Naomi Riches

Research Assistant Professor

University of Utah School of Medicine

UNITED STATES
View details

Nianjun Liu

Professor

Indiana University

UNITED STATES
View details